Content of Reissue Application
FederalAgency guidance
Ask Donna
How this section applies to your facts.
USPTO MPEP › Chapter 1400 - Correction of Patents › MPEP § 1410
Text
37 CFR 1.171 Application for reissue.
An application for reissue must contain the same parts required for an
application for an original patent, complying with all the rules relating thereto except
as otherwise provided, and in addition, must comply with the requirements of the rules
relating to reissue applications.
37 CFR 1.173 Reissue specification, drawings, and amendments.
(a)
Contents of a reissue application
. An application for reissue
must contain the entire specification, including the claims, and the drawings of
the patent. No new matter shall be introduced into the application. No reissue
patent shall be granted enlarging the scope of the claims of the original patent
unless applied for within two years from the grant of the original patent,
pursuant to
35
U.S.C. 251.
(1)
Specification, including claims.
The entire
specification, including the claims, of the patent for which reissue is
requested must be furnished in the form of a copy of the printed patent, in
double column format, each page on only one side of a single sheet of paper.
If an amendment of the reissue application is to be included, it must be
made pursuant to paragraph (b) of this section. The formal requirements for
papers making up the reissue application other than those set forth in this
section are set out in
§ 1.52
. Additionally, a
copy of any disclaimer (
§ 1.321
), certificate of
correction (
§§ 1.322
through
1.324
), or reexamination certificate
(
§
1.570
) issued in the patent must be included. (See
also
§
1.178
).
t must be
made pursuant to paragraph (b) of this section. The formal requirements for
papers making up the reissue application other than those set forth in this
section are set out in
§ 1.52
. Additionally, a
copy of any disclaimer (
§ 1.321
), certificate of
correction (
§§ 1.322
through
1.324
), or reexamination certificate
(
§
1.570
) issued in the patent must be included. (See
also
§
1.178
).
(2)
Drawings.
Applicant must submit a clean copy of each
drawing sheet of the printed patent at the time the reissue application is
filed. If such copy complies with
§ 1.84
, no further
drawings will be required. Where a drawing of the reissue application is to
include any changes relative to the patent being reissued, the changes to
the drawing must be made in accordance with paragraph (b)(3) of this
section. The Office will not transfer the drawings from the patent file to
the reissue application.
*****
The specification (including the claims and any drawings) of the reissue
application is the copy of the printed patent for which reissue is requested that is
submitted by applicant as part of the initial application papers. The copy of the printed
patent must be submitted in double column format, each page of double column format being
on only one side of the piece of paper. It should be noted that a re-typed specification is
not acceptable in a reissue application; the full copy of the printed patent must be used.
In addition, an applicant for reissue is required to file a reissue oath or declaration
which, in addition to complying with
37 CFR 1.63
, must comply with
37 CFR
1.175
. Where the patent has been assigned, the reissue applicant must
also provide a consent of assignee to the reissue and evidence of ownership. Where the
patent has not been assigned, the reissue applicant should affirmatively state that the
patent is not assigned.
An amendment may be submitted at the time of filing of a reissue
application
complying with
37 CFR 1.63
, must comply with
37 CFR
1.175
. Where the patent has been assigned, the reissue applicant must
also provide a consent of assignee to the reissue and evidence of ownership. Where the
patent has not been assigned, the reissue applicant should affirmatively state that the
patent is not assigned.
An amendment may be submitted at the time of filing of a reissue
application. The amendment may be made either by:
(A) physically incorporating the changes within the specification by
cutting the column of the printed patent and inserting the added material and
rejoining the remainder of the column and then joining the resulting modified column
to the other column of the printed patent. Markings pursuant to
37 CFR 1.173(d)
must be used to show the changes. The columnar structure of the printed patent must
be preserved, and the physically modified page must comply with
37 CFR
1.52(a)(1)
. As to compliance with
37 CFR
1.52(a)(1)(iv)
, the
"written either by a typewriter or machine printer in permanent dark ink or its
equivalent"
requirement is deemed to be satisfied where a
caret and line are drawn from a position within the text to a newly added phrase,
clause, sentence, etc. typed legibly in the margin; or
(B) providing a separate amendment paper with the reissue
application.
The presentation of the insertions or deletions as part of the original
reissue specification is an amendment under
37 CFR 1.173(b)
. An amendment of the
reissue application made at the time of filing of the reissue application must be made in
accordance with
37 CFR
1.173(b)-(e) and (g)
; see
MPEP § 1453
. Note that the provisions of
37 CFR
1.53(b)
, effective December 18, 2013, stating that an application may
be accorded a filing date “with or without” claims, does not apply in reissue applications,
as
37 CFR
1.173(a)(1)
requires the filing of the entire specification,
including the claims of the original patent
ication must be made in
accordance with
37 CFR
1.173(b)-(e) and (g)
; see
MPEP § 1453
. Note that the provisions of
37 CFR
1.53(b)
, effective December 18, 2013, stating that an application may
be accorded a filing date “with or without” claims, does not apply in reissue applications,
as
37 CFR
1.173(a)(1)
requires the filing of the entire specification,
including the claims of the original patent. A preliminary amendment cancelling all
original claims without presenting any new claims would be inappropriate under
37 CFR
1.115(b)(1)
. If an application is filed without claims, but otherwise
complies with
37 CFR
1.53(b)
and the reissue rules, the Office of Patent Application
Processing (OPAP) will accord a filing date and send out a notice of missing parts setting
a period of time for filing the missing part and for payment of any surcharge required
under
37 CFR
1.53(f)
and
37 CFR 1.16(f)
.
If the changes to be made to the patent are so extensive that reading and
understanding the specification is extremely difficult and error-prone, a clean, typed copy
of the specification may be submitted if accompanied by a grantable petition under
37 CFR
1.183
for waiver of
37 CFR 1.125(d)
and
37 CFR
1.173(a)(1)
.
Pursuant to
37 CFR 1.173(a)(1)
, applicant is
required to include a copy of any disclaimer (
37 CFR 1.321
), certificate of
correction (
37 CFR
1.322
–
1.324
), reexamination certificate
(
37 CFR
1.570
and
1.997
) or certificate from a trial
before the Patent Trial and Appeal Board (PTAB) (
37 CFR
42.80
) issued in the patent for which reissue is requested. If there
was a prior change to the patent (made via a certificate, reissue of the patent,
disclaimer, etc.), the first amendment of the subject reissue application must be made
relative to the patent as changed by the prior proceeding or other mechanism for changing
the patent
rial
before the Patent Trial and Appeal Board (PTAB) (
37 CFR
42.80
) issued in the patent for which reissue is requested. If there
was a prior change to the patent (made via a certificate, reissue of the patent,
disclaimer, etc.), the first amendment of the subject reissue application must be made
relative to the patent as changed by the prior proceeding or other mechanism for changing
the patent.
It should also be noted that
37 CFR 1.178(b)
requires reissue applicants to call to the attention of the Office any prior or concurrent
proceedings in which the patent (for which reissue is requested) is or was involved, such
as interferences, reissues, reexaminations, or litigation (litigation covers any papers
filed in the court or issued by the court, such as, for example, motions, pleadings, and
court decisions including court orders) and the results of such proceedings. This duty is a
continuing duty, and runs from the time the reissue application is filed until the reissue
application is abandoned or issues as a reissue patent.
It is no longer required that the reissue applicant physically surrender
the original patent, see
MPEP § 1416
.
When appropriate, the reissue applicant must provide a claim for
priority/benefit under
35
U.S.C. 119
or
120
in the reissue application. Benefit
and priority claims made in the patent for which reissue is sought do not carry over into
the reissue application. For any reissue filed on or after September 16, 2012, the
priority/benefit claim information must be in an application data sheet (ADS) under
37 CFR
1.76
and must be made within the time period set forth in
37 CFR
1.55
and
1.78
unless a petition for an
unintentionally delayed priority or benefit claim is filed. See
MPEP § 1402
, subsections
III and IV, for more information. An ADS is also required if an application under
35 U.S.C.
111(a)
is made by a person other than the inventor.
Where appropriate, the reissue applicant may also file an
Information Disclosure Statement
the time period set forth in
37 CFR
1.55
and
1.78
unless a petition for an
unintentionally delayed priority or benefit claim is filed. See
MPEP § 1402
, subsections
III and IV, for more information. An ADS is also required if an application under
35 U.S.C.
111(a)
is made by a person other than the inventor.
Where appropriate, the reissue applicant may also file an
Information Disclosure Statement.
A reissue application that discloses nucleotide and/or
amino acid sequences must comply with the sequence rules (
37 CFR
1.831
-
37 CFR 1.839
for reissue applications
filed on or after July 1, 2022 and
37 CFR 1.821
-
1.825
for reissue
applications filed before July 1, 2022). See
MPEP §
2412
et seq.
for detailed information pertaining to the submission of
“Sequence Listing XMLs” and
MPEP § 2422.03
et seq.
for detailed information pertaining to the submission of
"Sequence Listings".
The initial contents of a reissue application are discussed in detail in
MPEP §
1410.01
through
§ 1418
.
For expedited processing, new and continuing reissue application filings
under
37 CFR
1.53(b)
may be addressed to: Mail Stop REISSUE, Commissioner for
Patents, P.O. Box 1450, Alexandria, VA 22313-1450. Mail Stop REISSUE should only be used
for the initial filing of reissue applications, and should
not
be
used for any subsequently filed correspondence in reissue applications. Reissue
applications may be filed through the USPTO patent electronic filing system. See
MPEP §
502.05
. When filing a reissue application electronically, an
applicant should choose the “reissue” radio button. Regardless of the manner of filing, all
new reissue filings should include a copy of a completed Reissue Patent Application
Transmittal Form (PTO/AIA/50) to ensure that the filing of the new application will be
recognized as a reissue application.
The oath or declaration, any matters ancillary thereto (such as the
consent of assignee), and the basic filing fee, search fee, and examination fee may be
submitted after the filing date pursuant to
37 CFR 1.53(f)
ould include a copy of a completed Reissue Patent Application
Transmittal Form (PTO/AIA/50) to ensure that the filing of the new application will be
recognized as a reissue application.
The oath or declaration, any matters ancillary thereto (such as the
consent of assignee), and the basic filing fee, search fee, and examination fee may be
submitted after the filing date pursuant to
37 CFR 1.53(f)
.
The assignee entity is established by a statement on behalf of all the
assignees under
37 CFR
1.172(a)
and
37 CFR 3.73
. See
MPEP § 1410.01
.
A guide for filing reissue applications on or after
September 16, 2012 is available at
www.uspto.gov/sites/default/files/forms/
uspto_reissue_ads_guide_Sept2014.pdf
Form PTO/AIA/50, Reissue Patent Application Transmittal, which may be used
for filing reissue applications, is reproduced below.
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.